A Phase 1 Study of the Safety and Tolerability of CTX-10726
Compass Therapeutics
Compass Therapeutics
Rutgers, The State University of New Jersey
Kaiser Permanente
Second Life Therapeutics
Universidade Federal de Pernambuco
Danatlas Pharmaceuticals Co., Ltd